WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) saw unusually-strong trading volume on Monday . 10,262 shares were traded during mid-day trading, an increase of 348% from the previous session’s volume of 2,290 shares.The stock last traded at $25.50 and had previously closed at $26.17.
Analysts Set New Price Targets
Separately, Zacks Research upgraded WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.
Check Out Our Latest Analysis on WUXAY
WuXi AppTec Trading Down 2.6%
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Recommended Stories
- Five stocks we like better than WuXi AppTec
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
